Terms: = Ovarian cancer AND BCOR, ANOP2, 54880, ENSG00000183337, MAA2, MCOPS2, FLJ38041, KIAA1575, MGC131961, FLJ20285, MGC71031
17 results:
1. CTNNB1 p.D32A (c.95A > C) somatic mutation in stage I grade 1 endometrioid endometrial carcinoma with lung metastasis: a case report.
Zhong L; Jiang W; RutieYin ; Liu H; Song L
BMC Med Genomics; 2023 Jun; 16(1):137. PubMed ID: 37328769
[TBL] [Abstract] [Full Text] [Related]
2. A comprehensive immunohistochemical analysis of 26 markers in 250 cases of serous ovarian tumors.
Němejcová K; Šafanda A; Bártů MK; Michálková R; Drozenová J; Fabian P; Hausnerová J; Laco J; Matěj R; Méhes G; Škapa P; Stružinská I; Dundr P
Diagn Pathol; 2023 Feb; 18(1):32. PubMed ID: 36855066
[TBL] [Abstract] [Full Text] [Related]
3. Endometrial stromal tumors of the uterus: Epidemiology, pathological and biological features, treatment options and clinical outcomes.
Gadducci A; Multinu F; De Vitis LA; Cosio S; Carinelli S; Aletti GD
Gynecol Oncol; 2023 Apr; 171():95-105. PubMed ID: 36842409
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of Lineage/Site-specific Nuclear Immunohistochemical Markers SATB2, Cyclin D1, SALL4, and bcor in High-grade Endometrial Carcinomas.
Dyhdalo KS; Ababneh E; Lanigan C; Bowers K; Zhang S; McKenney JK; Joehlin-Price AS
Int J Gynecol Pathol; 2023 Sep; 42(5):443-450. PubMed ID: 36731037
[TBL] [Abstract] [Full Text] [Related]
5. NCOA1/2/3 rearrangements in uterine tumor resembling ovarian sex cord tumor: A clinicopathological and molecular study of 18 cases.
Lu B; Xia Y; Chen J; Tang J; Shao Y; Yu W
Hum Pathol; 2023 May; 135():65-75. PubMed ID: 36646185
[TBL] [Abstract] [Full Text] [Related]
6. Highly Invasive and Metastatic High-grade Endometrial Stromal Sarcoma With
Ling F; Ruan S; Chen H; Xiong X; Zhao D; Haybaeck J; Zhang C
In Vivo; 2022; 36(4):1971-1976. PubMed ID: 35738637
[TBL] [Abstract] [Full Text] [Related]
7. Update on Uterine Mesenchymal Neoplasms.
Kertowidjojo EC; Bennett JA
Surg Pathol Clin; 2022 Jun; 15(2):315-340. PubMed ID: 35715164
[TBL] [Abstract] [Full Text] [Related]
8. Molecular Heterogeneity of Endometrioid ovarian Carcinoma: An Analysis of 166 Cases Using the Endometrial cancer Subrogate Molecular Classification.
Leskela S; Romero I; Rosa-Rosa JM; Caniego-Casas T; Cristobal E; Pérez-Mies B; Gutierrez-Pecharroman A; Santón A; Ojeda B; López-Reig R; Palacios-Berraquero ML; Andrada E; Montes S; Pastor F; Gomez MC; López-Guerrero JA; Poveda A; Palacios J
Am J Surg Pathol; 2020 Jul; 44(7):982-990. PubMed ID: 32384322
[TBL] [Abstract] [Full Text] [Related]
9. Endometrial stromal sarcomas with bcor-rearrangement harbor MDM2 amplifications.
Kommoss FK; Chang KT; Stichel D; Banito A; Jones DT; Heilig CE; Fröhling S; Sahm F; Stenzinger A; Hartmann W; Mechtersheimer G; Sinn HP; Schmidt D; Kommoss F; von Deimling A; Koelsche C
J Pathol Clin Res; 2020 Jul; 6(3):178-184. PubMed ID: 32352245
[TBL] [Abstract] [Full Text] [Related]
10. ovarian mucinous tumors with mural nodules: immunohistochemical and molecular analysis of 3 cases.
Shao Y; Liu Q; Shi H; Lu B
Diagn Pathol; 2020 Apr; 15(1):35. PubMed ID: 32290854
[TBL] [Abstract] [Full Text] [Related]
11. Uterine mesenchymal tumours: recent advances.
Momeni-Boroujeni A; Chiang S
Histopathology; 2020 Jan; 76(1):64-75. PubMed ID: 31846533
[TBL] [Abstract] [Full Text] [Related]
12. DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics.
Kommoss FKF; Stichel D; Schrimpf D; Kriegsmann M; Tessier-Cloutier B; Talhouk A; McAlpine JN; Chang KTE; Sturm D; Pfister SM; Romero-Pérez L; Kirchner T; Grünewald TGP; Buslei R; Sinn HP; Mechtersheimer G; Schirmacher P; Schmidt D; Lehr HA; Sahm F; Huntsman DG; Gilks CB; Kommoss F; von Deimling A; Koelsche C
J Cancer Res Clin Oncol; 2020 Jan; 146(1):97-104. PubMed ID: 31768620
[TBL] [Abstract] [Full Text] [Related]
13. Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma.
Cuevas D; Valls J; Gatius S; Roman-Canal B; Estaran E; Dorca E; Santacana M; Vaquero M; Eritja N; Velasco A; Matias-Guiu X
Virchows Arch; 2019 May; 474(5):585-598. PubMed ID: 30710169
[TBL] [Abstract] [Full Text] [Related]
14. [Mesenchymal and mixed uterine tumors : Current overview and practical aspects].
Lax SF
Pathologe; 2019 Feb; 40(1):36-45. PubMed ID: 30694356
[TBL] [Abstract] [Full Text] [Related]
15. Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma.
García-Sanz P; Triviño JC; Mota A; Pérez López M; Colás E; Rojo-Sebastián A; García Á; Gatius S; Ruiz M; Prat J; López-López R; Abal M; Gil-Moreno A; Reventós J; Matias-Guiu X; Moreno-Bueno G
Int J Cancer; 2017 Apr; 140(7):1551-1563. PubMed ID: 27997699
[TBL] [Abstract] [Full Text] [Related]
16. Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition.
Zhao S; Bellone S; Lopez S; Thakral D; Schwab C; English DP; Black J; Cocco E; Choi J; Zammataro L; Predolini F; Bonazzoli E; Bi M; Buza N; Hui P; Wong S; Abu-Khalaf M; Ravaggi A; Bignotti E; Bandiera E; Romani C; Todeschini P; Tassi R; Zanotti L; Odicino F; Pecorelli S; Donzelli C; Ardighieri L; Facchetti F; Falchetti M; Silasi DA; Ratner E; Azodi M; Schwartz PE; Mane S; Angioli R; Terranova C; Quick CM; Edraki B; Bilgüvar K; Lee M; Choi M; Stiegler AL; Boggon TJ; Schlessinger J; Lifton RP; Santin AD
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12238-12243. PubMed ID: 27791010
[TBL] [Abstract] [Full Text] [Related]
17. bcor-L1 variation and breast cancer.
Lose F; Arnold J; Young DB; Brown CJ; Mann GJ; Pupo GM; ; Khanna KK; Chenevix-Trench G; Spurdle AB
Breast Cancer Res; 2007; 9(4):R54. PubMed ID: 17697391
[TBL] [Abstract] [Full Text] [Related]
